BRPI1014821A2 - "inibidores de replicação de hiv" - Google Patents
"inibidores de replicação de hiv"Info
- Publication number
- BRPI1014821A2 BRPI1014821A2 BRPI1014821A BRPI1014821A BRPI1014821A2 BR PI1014821 A2 BRPI1014821 A2 BR PI1014821A2 BR PI1014821 A BRPI1014821 A BR PI1014821A BR PI1014821 A BRPI1014821 A BR PI1014821A BR PI1014821 A2 BRPI1014821 A2 BR PI1014821A2
- Authority
- BR
- Brazil
- Prior art keywords
- hiv replication
- replication inhibitors
- inhibitors
- hiv
- replication
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 230000010076 replication Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- AIDS & HIV (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16803209P | 2009-04-09 | 2009-04-09 | |
| US26368909P | 2009-11-23 | 2009-11-23 | |
| PCT/CA2010/000478 WO2010115264A1 (en) | 2009-04-09 | 2010-04-07 | Inhibitors of hiv replication |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1014821A2 true BRPI1014821A2 (pt) | 2016-04-05 |
Family
ID=42934876
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1014821A BRPI1014821A2 (pt) | 2009-04-09 | 2010-04-07 | "inibidores de replicação de hiv" |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8349839B2 (pt) |
| EP (1) | EP2417140B1 (pt) |
| JP (1) | JP5643290B2 (pt) |
| KR (1) | KR20120034592A (pt) |
| CN (1) | CN102388051A (pt) |
| AR (1) | AR076252A1 (pt) |
| AU (1) | AU2010234241A1 (pt) |
| BR (1) | BRPI1014821A2 (pt) |
| CA (1) | CA2758149A1 (pt) |
| CL (1) | CL2011002258A1 (pt) |
| EA (1) | EA201101397A1 (pt) |
| IL (1) | IL214606A0 (pt) |
| MX (1) | MX2011010582A (pt) |
| TW (1) | TW201103940A (pt) |
| WO (1) | WO2010115264A1 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9399645B2 (en) * | 2011-12-20 | 2016-07-26 | Boehringer Ingelheim International Gmbh | Inhibitors of HIV replication |
| WO2016114816A1 (en) * | 2015-01-18 | 2016-07-21 | Sri International | MAP4K4 (HGK) Inhibitors |
| ES2770123T3 (es) | 2015-02-02 | 2020-06-30 | Forma Therapeutics Inc | Acidos 3-alquil-4-amido-bicíclicos [4,5,0]hidroxámicos como inhibidores de HDAC |
| TW201636329A (zh) | 2015-02-02 | 2016-10-16 | 佛瑪治療公司 | 作為ｈｄａｃ抑制劑之雙環［４，６，０］異羥肟酸 |
| EP3472131B1 (en) | 2016-06-17 | 2020-02-19 | Forma Therapeutics, Inc. | 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors |
| MX2020006587A (es) | 2017-12-22 | 2020-12-10 | Ravenna Pharmaceuticals Inc | Derivados de aminopiridina como inhibidores de fosfatidilinositol fosfato cinasa. |
| WO2020028482A1 (en) * | 2018-07-31 | 2020-02-06 | The Trustees Of The University Of Pennsylvania | Small molecules that sensitize hiv-1 infected cells to antibody dependent cellular cytotoxicity |
| TW202112767A (zh) | 2019-06-17 | 2021-04-01 | 美商佩特拉製藥公司 | 作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物 |
| CN111560022A (zh) * | 2020-05-13 | 2020-08-21 | 深圳职业技术学院 | 四氢苯并呋喃[3,2-d]嘧啶类衍生物及其制备方法及应用 |
| CN116332947A (zh) * | 2021-12-24 | 2023-06-27 | 上海海和药物研究开发股份有限公司 | 具有mat2a抑制活性的嘧啶-2(1h)-酮并二环类化合物及其用途 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8016A (en) * | 1851-04-01 | Improvement in the manufacture of india-rubber | ||
| JPH06172365A (ja) * | 1992-12-11 | 1994-06-21 | Yamasa Shoyu Co Ltd | １０−チアイソアロキサジン誘導体およびその用途 |
| JPH06220059A (ja) * | 1993-01-28 | 1994-08-09 | Tanabe Seiyaku Co Ltd | 縮合ピリミジン誘導体及びその製法 |
| US6593337B1 (en) * | 1999-10-19 | 2003-07-15 | Bristol-Myers Squibb Pharma Company | Tricyclic compounds useful as HIV reverse transcriptase inhibitors |
| EP1209158A1 (en) | 2000-11-18 | 2002-05-29 | Aventis Pharma Deutschland GmbH | Substituted beta-carbolines |
| TWI270547B (en) * | 2000-06-16 | 2007-01-11 | Boehringer Ingelheim Ca Ltd | Non-nucleoside reverse transcriptase inhibitors |
| WO2003099206A2 (en) | 2002-05-21 | 2003-12-04 | Bristol-Myers Squibb Company | Indole compounds useful as impdh inhibitors |
| US20030139427A1 (en) | 2002-08-23 | 2003-07-24 | Osi Pharmaceuticals Inc. | Bicyclic pyrimidinyl derivatives and methods of use thereof |
| JP4532281B2 (ja) | 2002-11-08 | 2010-08-25 | 株式会社カネカ | エルゴステロールの分離方法 |
| AU2003296760B2 (en) | 2002-11-15 | 2009-11-19 | Tibotec Pharmaceuticals Ltd. | Substituted indolepyridinium as anti-infective compounds |
| US7642277B2 (en) | 2002-12-04 | 2010-01-05 | Boehringer Ingelheim International Gmbh | Non-nucleoside reverse transcriptase inhibitors |
| EP1625130A2 (en) * | 2003-04-28 | 2006-02-15 | Tibotec Pharmaceuticals Ltd. | Hiv integrase inhibitors |
| US20060074124A1 (en) | 2003-09-12 | 2006-04-06 | Andrew Napper | Methods of treating a disorder |
| AU2004285449A1 (en) * | 2003-10-20 | 2005-05-12 | Merck & Co., Inc. | Hydroxy pyridopyrrolopyrazine dione compounds useful as HIV integrase inhibitors |
| US7875604B2 (en) * | 2004-02-04 | 2011-01-25 | University Of Virginia Patent Foundation | Compounds that inhibit HIV particle formation |
| TW200613307A (en) * | 2004-05-17 | 2006-05-01 | Tibotec Pharm Ltd | 4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones |
| AR049340A1 (es) | 2004-05-17 | 2006-07-19 | Tibotec Pharm Ltd | 1- heterociclil - l, 5- dihidro- pirido (3,2-b) indol - 2- onas |
| DE602005023600D1 (de) | 2004-05-17 | 2010-10-28 | Little Island Co Cork | Substituierte 1-phenyl-1,5-dihydro-pyridoä3,2-büindol-2-on-derivate verwendbar als pharmazeutische antiinfektiva |
| MXPA06013316A (es) * | 2004-05-17 | 2007-02-02 | Tibotec Pharm Ltd | Combinaciones de 1-fenil-1,5-dihidro-pirido-[3,2-b]indol-2-onas sustituidas y otros inhibidores de virus de inmunodeficiencia humana. |
| RU2362776C2 (ru) | 2004-05-17 | 2009-07-27 | Тиботек Фармасьютикалз Лтд. | 5-ЗАМЕЩЕННЫЕ 1-ФЕНИЛ-1,5-ДИГИДРОПИРИДО[3,2-b]ИНДОЛ-2-ОНЫ И АНАЛОГИ КАК ПРОТИВОВИРУСНЫЕ ПРЕПАРАТЫ |
| EP1773840B1 (de) * | 2004-07-23 | 2010-01-20 | The Medicines Company (Leipzig) GmbH | Substituierte pyrido[3',2':4,5]thieno[3,2-d]pyrimidine und pyrido[3',2':4,5]furo[3,2-d]-pyrimidine zur verwendung als inhibitoren der pda-4 und/oder tnf-alpha freisetzung |
| CA2577144C (en) | 2004-09-30 | 2011-06-21 | Boehringer Ingelheim International Gmbh | Alkynyl compounds as non-nucleoside reverse transcriptase inhibitors |
| JP2008515982A (ja) | 2004-10-13 | 2008-05-15 | メルク エンド カムパニー インコーポレーテッド | 高眼圧症を治療するための眼科組成物 |
| EA014956B1 (ru) | 2004-12-17 | 2011-04-29 | ГЛЕНМАРК ФАРМАСЬЮТИКАЛС Эс.Эй. | Гетероциклические соединения, применяемые для лечения воспалительных и аллергических нарушений |
| US20060276440A1 (en) | 2005-01-03 | 2006-12-07 | An Wenqian F | Treatment of inflammatory disorders |
| WO2007025090A2 (en) | 2005-08-25 | 2007-03-01 | Kalypsys, Inc. | Heterobicyclic and - tricyclic inhibitors of mapk/erk kinase |
| JP2009525310A (ja) | 2006-02-03 | 2009-07-09 | テイボテク・フアーマシユーチカルズ・リミテツド | 突然変異したｈｉｖを処置する方法 |
| WO2008037783A1 (en) | 2006-09-29 | 2008-04-03 | Tibotec Pharmaceuticals Ltd. | Process for preparing 2-oxo-2,5-dihydro-1h-pyrido[3,2-b]indole-3-carbonitriles |
| DE102006062203A1 (de) * | 2006-12-22 | 2008-06-26 | Curacyte Discovery Gmbh | Substituierte 5H-Pyrimido[5,4-b]indole als Induktoren der Apoptose bei B-CLL Zellen |
| US20100120799A1 (en) | 2007-02-19 | 2010-05-13 | Smithkline Beecham Corporation | Purine derivatives as immunomodulators |
| WO2008119070A1 (en) | 2007-03-28 | 2008-10-02 | Trustees Of Boston University | Methods of treatment using sirt modulators and compositions containing sirt1 modulators |
| WO2009085185A1 (en) | 2007-12-19 | 2009-07-09 | Amgen Inc. | Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors |
-
2010
- 2010-04-07 CA CA2758149A patent/CA2758149A1/en not_active Abandoned
- 2010-04-07 CN CN2010800156236A patent/CN102388051A/zh active Pending
- 2010-04-07 KR KR1020117023696A patent/KR20120034592A/ko not_active Withdrawn
- 2010-04-07 EA EA201101397A patent/EA201101397A1/ru unknown
- 2010-04-07 WO PCT/CA2010/000478 patent/WO2010115264A1/en not_active Ceased
- 2010-04-07 AU AU2010234241A patent/AU2010234241A1/en not_active Abandoned
- 2010-04-07 EP EP10761139.4A patent/EP2417140B1/en active Active
- 2010-04-07 MX MX2011010582A patent/MX2011010582A/es unknown
- 2010-04-07 JP JP2012503835A patent/JP5643290B2/ja active Active
- 2010-04-07 BR BRPI1014821A patent/BRPI1014821A2/pt not_active Application Discontinuation
- 2010-04-08 AR ARP100101202A patent/AR076252A1/es unknown
- 2010-04-08 TW TW099110936A patent/TW201103940A/zh unknown
- 2010-04-08 US US12/756,276 patent/US8349839B2/en active Active
-
2011
- 2011-08-11 IL IL214606A patent/IL214606A0/en unknown
- 2011-09-12 CL CL2011002258A patent/CL2011002258A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201103940A (en) | 2011-02-01 |
| IL214606A0 (en) | 2011-09-27 |
| US20100261714A1 (en) | 2010-10-14 |
| CN102388051A (zh) | 2012-03-21 |
| CA2758149A1 (en) | 2010-10-14 |
| MX2011010582A (es) | 2011-10-19 |
| EA201101397A1 (ru) | 2012-05-30 |
| KR20120034592A (ko) | 2012-04-12 |
| AR076252A1 (es) | 2011-05-26 |
| JP5643290B2 (ja) | 2014-12-17 |
| EP2417140B1 (en) | 2014-11-26 |
| CL2011002258A1 (es) | 2012-02-10 |
| JP2012523380A (ja) | 2012-10-04 |
| US8349839B2 (en) | 2013-01-08 |
| EP2417140A1 (en) | 2012-02-15 |
| WO2010115264A1 (en) | 2010-10-14 |
| EP2417140A4 (en) | 2013-02-20 |
| AU2010234241A1 (en) | 2011-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2021008I2 (el) | Πυριμιδινες οι οποιες παρεμποδιζουν την ανατυπωση ηιv | |
| CY2018030I2 (el) | Φαρμακοτεχνικη μορφη 514 | |
| BRPI0910307A2 (pt) | inibidores de hiv integrase | |
| FR16C1026I2 (fr) | Inhibiteurs de la replication du virus de l'hepatite c | |
| BR112012012872A2 (pt) | "pirrolindinas de espiroindolinona" | |
| BR112012014254A2 (pt) | "artigo de múltiplas camadas" | |
| CR10693A (es) | Enantiomerically pure phosphoindoles as hiv inhibitors | |
| BRPI1009315A2 (pt) | agentes anti-inflamatórios | |
| BRPI1012004A2 (pt) | "forma farmacêutica" | |
| EP2263545A4 (en) | sonographer | |
| BRPI1014821A2 (pt) | "inibidores de replicação de hiv" | |
| BRPI1014956A2 (pt) | agentes antinflamatórios. | |
| BR112012003780A2 (pt) | pregão semântico | |
| EP2414948A4 (en) | APPLICATION SHARING | |
| BRPI0920521A2 (pt) | combinação farmacêutica | |
| DK3097925T3 (da) | Farmaceutisk sammensætning | |
| LT3061445T (lt) | Labai koncentruotos farmacinės kompozicijos | |
| BRPI1004940A2 (pt) | composição farmacêutica | |
| BR112012004593A2 (pt) | "método" | |
| BR112012010595A2 (pt) | "dispensdor" | |
| BRPI1015939A2 (pt) | composição farmacêutica | |
| EP2099789A4 (en) | INHIBITORS OF HIV REPLICATION | |
| EP2189118A4 (en) | ULTRASOUND DEVICE | |
| FR2944062B1 (fr) | Injecteur d'ergols | |
| BR112012003149A2 (pt) | composição farmacêutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |